These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8738706)

  • 1. Retinopathy in diabetic hypertensive monkeys: a pathologic study.
    Büchi ER; Kurosawa A; Tso MO
    Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):388-98. PubMed ID: 8738706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinopathy in monkeys with spontaneous type 2 diabetes.
    Kim SY; Johnson MA; McLeod DS; Alexander T; Otsuji T; Steidl SM; Hansen BC; Lutty GA
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4543-53. PubMed ID: 15557466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.
    Tolentino MJ; McLeod DS; Taomoto M; Otsuji T; Adamis AP; Lutty GA
    Am J Ophthalmol; 2002 Mar; 133(3):373-85. PubMed ID: 11860975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microangiopathic retinopathy in experimental diabetic monkeys.
    Tso MO; Kurosawa A; Benhamou E; Bauman A; Jeffrey J; Jonasson O
    Trans Am Ophthalmol Soc; 1988; 86():389-421. PubMed ID: 2980946
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral retinal evaluation comparing fundus photographs with fluorescein angiograms in patients with diabetes mellitus.
    Agardh E; Cavallin-Sjöberg U
    Retina; 1998; 18(5):420-3. PubMed ID: 9801036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundus lesions in malignant hypertension. IV. Focal intraretinal periarteriolar transudates.
    Hayreh SS; Servais GE; Virdi PS
    Ophthalmology; 1986 Jan; 93(1):60-73. PubMed ID: 3951817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term features of diabetic retinopathy in streptozotocin-induced diabetic Wistar rats.
    Naderi A; Zahed R; Aghajanpour L; Amoli FA; Lashay A
    Exp Eye Res; 2019 Jul; 184():213-220. PubMed ID: 31028750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal arteriolar changes in malignant arterial hypertension.
    Hayreh SS; Servais GE; Virdi PS
    Ophthalmologica; 1989; 198(4):178-96. PubMed ID: 2748097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Talc retinopathy in primates. A model of ischemic retinopathy: I. Clinical studies.
    Jampol LM; Setogawa T; Rednam KR; Tso MO
    Arch Ophthalmol; 1981 Jul; 99(7):1273-80. PubMed ID: 7196216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.
    McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J
    Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotton-wool spots (inner retinal ischemic spots) in malignant arterial hypertension.
    Hayreh SS; Servais GE; Virdi PS
    Ophthalmologica; 1989; 198(4):197-215. PubMed ID: 2748098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
    Tolentino MJ; Miller JW; Gragoudas ES; Jakobiec FA; Flynn E; Chatzistefanou K; Ferrara N; Adamis AP
    Ophthalmology; 1996 Nov; 103(11):1820-8. PubMed ID: 8942877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic studies of the blood--retinal barrier in the spontaneously diabetic BB rat.
    Blair NP; Tso MO; Dodge JT
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):302-11. PubMed ID: 6698748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus.
    Tso MO; Cunha-Vaz JG; Shih CY; Jones CW
    Arch Ophthalmol; 1980 Nov; 98(11):2032-40. PubMed ID: 7436840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys.
    Hofman P; Blaauwgeers HG; Vrensen GF; Schlingemann RO
    Ophthalmic Res; 2001; 33(3):156-62. PubMed ID: 11340407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein angiography of peripheral retina and pars plana during vitrectomy for proliferative diabetic retinopathy.
    Terasaki H; Miyake Y; Awaya S
    Am J Ophthalmol; 1997 Mar; 123(3):370-6. PubMed ID: 9063247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.
    van Gerven JM; Boot JP; Lemkes HH; van Best JA
    Doc Ophthalmol; 1992; 80(2):183-8. PubMed ID: 1425133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
    Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
    Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.